Effectiveness and tolerability of nimotuzumab in unresectable, locally advanced/metastatic esophageal cancer: Indian hospital-based retrospective evidence

CONTEXT: Epidermal growth factor receptor (EGFR) is overly expressed in esophageal squamous cell carcinoma (ESCC) and is important prognostic and predictive biomarker. Nimotuzumab is a humanized anti-EGFR monoclonal antibody and has documented promising clinical outcomes and survival rates in variou...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:South Asian J Cancer
Hlavní autoři: Subramanian, Sundaram, Sridharan, Nithya, Balasundaram, V., Chaudhari, Sameer
Médium: Artigo
Jazyk:Inglês
Vydáno: Wolters Kluwer - Medknow 2019
Témata:
ORIGINAL ARTICLE: Head and Neck Cancers
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6498719/
https://ncbi.nlm.nih.gov/pubmed/31069192
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/sajc.sajc_89_18
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky